Universal Cholesterol Screening for Children: A Critical Step to Prevent Heart Disease
In a groundbreaking move, the Canadian Paediatric Society has released a new position statement advocating for universal cholesterol screening in all children between the ages of two and ten. This recommendation aims to address the often-overlooked issue of high cholesterol in young populations, which can lead to serious heart conditions later in life if left untreated.
The Genetic Basis of Cholesterol in Children
While many associate high cholesterol with poor diet and sedentary lifestyles in adults, genetics play a pivotal role from conception. Dr. Christopher Labos emphasizes that cholesterol levels are significantly influenced by inherited factors, making even children susceptible to elevated levels. This genetic predisposition means that cholesterol disorders are not exclusive to older individuals but can manifest early, necessitating proactive measures.
Cholesterol is more complex than simply good versus bad. Components like triglycerides fluctuate with diet, whereas others, such as Lp(a), are genetically determined and remain stable throughout life. This complexity underscores the importance of early detection, as treating high cholesterol in childhood can effectively prevent cardiovascular diseases in adulthood.
Prevalence and Regional Variations
Cholesterol disorders in children, though rare, are more common than perceived. Familial hypercholesterolemia, a genetic condition, affects approximately one in 300 children nationwide. In Quebec, the prevalence is nearly three times higher due to the founder effect—a phenomenon where a small group of settlers, primarily from northwestern France, carried a rare cholesterol mutation that became widespread over generations.
This historical context highlights why targeted screening is crucial, especially in regions with higher genetic risks. Without routine checks, many cases go undiagnosed, as evidenced by low screening rates across North America.
Current Screening Practices and Gaps
A 2017 survey revealed that less than half of American pediatricians were aware of cholesterol screening guidelines, with only 11% of children aged nine to 21 having recorded tests. In Canada, the situation is even more concerning: a 2020 study found that merely 3% of pediatricians practice universal screening for nine- to eleven-year-olds. Screening rates improve slightly for older children or those with obesity, but the goal is to identify issues in seemingly healthy individuals early on.
Alarmingly, when faced with a hypothetical case of severe high cholesterol in a child, only 7% of pediatricians in the survey indicated they would initiate treatment themselves, while most would refer to specialists. This hesitation points to a need for better education and confidence in managing pediatric cholesterol disorders.
Treatment Efficacy and Safety
Statins, often subject to misinformation, have proven safe and effective for treating high cholesterol in children. A 2019 Cochrane review of nine studies confirmed their effectiveness without safety concerns. Additionally, a 20-year follow-up study demonstrated that statin therapy in children with familial hypercholesterolemia slowed plaque progression and reduced cardiovascular events, reinforcing the value of early intervention.
It may seem unconventional to focus on cholesterol in kids, but genetically mediated conditions are more prevalent than realized. As Dr. Labos notes, "Unless you check for it, you will never find it. Unless you find it, you will never treat it. And if you don’t treat it, you won’t prevent the heart disease that’s coming down the road." This call to action underscores the urgency of adopting universal screening to safeguard children's long-term health.
